Multidrug resistance in the world: The present situation

Chemotherapy

Volumn 42, Issue , 1996, Pages 2-9

  Reichman, Lee B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Drug resistance; Fluoroquinolones; Multidrug resistant tuberculosis; Ofloxacin

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; SPARFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ABDOMINAL PAIN; ANOREXIA; BACTERICIDAL ACTIVITY; CHEMOPROPHYLAXIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG BIOAVAILABILITY; FEVER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAISE; MULTIDRUG RESISTANCE; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; VOMITING;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; GUIDELINES; HUMANS; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICES; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0029904684     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239506     Document Type: Article

References (18)

1. Anonymous: Tuberculosis: A global emergency. World Health Forum 1993; 14:438.
2. Raviglione MC, Snider DE, Kochi A: Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273:220-226.
3. Iscman MD: Evolution of drug resistant tuberculosis: A tale of two species. Proc Natl Acad Sci USA 1994; 91:2428-2429.
4. Frciden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW: The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993;328: 512-526.
5. Mitchison DA: Basic mechanisms of chemotherapy. Chest 1979;76: 771S-781S.
6. Mahmoudi A, Iseman MD: Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65-68.
7. O’Brien RJ: The treatment of tuberculosis; in Reichman LB, Hershficld ES (eds): Tuberculosis: A Comprehensive International Approach. New York, Dekker, 1993, pp 207-234.
8. American Thoracic Society and the Centers for Disease Control and Prevention: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149:1359-1374.
9. Moulding T, Dutt AK, Reichman LB: Fixed dose combinations of antituberculosis medications to prevent drug resistance. Ann Intern Med 1995;122:951-954.
10. Sumartojo E: When tuberculosis trcatmant fails. Am Rev Respir Dis 1993;147:1311-1315.
11. Iscman MD, Cohn DL, Sbarbaro JA: Directly observed treatment of tuberculosis: Wc can’t afford not to try it. N Engl J Med 1993;328:576-578.
12. Frieden TR, Fujiwara PI, Washko RM, Hamburg MJ: Tuberculosis in New York city: Turning the tide. N Engl J Med 1995;333:299-303.
13. Galanowski K, Napolitano E, Wolman M, Timmer G, McDonald RJ, Mangura BT, Reichman LB: Directly observed therapy (DOT) is not the entire answer. Am J Respir Crit Care Med 1996; 153:A491.
14. Acocella G: Human bioavailability studies. Bull Int Union Tubcrc Lung Dis 1989;64:38-40.
15. O’Brien RJ, Nunn PP: Ciprofloxacin is not a component of first line TB. Chest 1994:106:1372.
16. Reichman LB: Multidrug resistant tuberculosis: Meeting the challenge. HospPract 1994;29:85-96.
17. Geiter LJ: Preventive therapy; in Reichman LB, Hershfield ES (eds): Tuberculosis: A Comprehensive International Approach. New York, Dekker, 1993, pp 241-250.
18. Passannante MR, Gallagher CT, Reichman LB: Preventive therapy for contacts of multidrug resistant tuberculosis: A Delphi survey. Chest 1994:106:431-434.